This week we highlight the 340B drug pricing program, oncology clinical trials, balancing patient privacy concerns with data needs for artificial intelligence and more. … READ MORE >
life sciences
5 things to know in life sciences: Week of May 10
This week we highlight small-company drug launches during the pandemic, the future of the biopharma office, using artificial intelligence to diagnose rare diseases and more. … READ MORE >
5 things to know in life sciences: Week of May 3
This week we highlight herd immunity challenges, concerns about waiving patent protections on COVID-19 vaccines, using machine learning to reduce trial risks and more. … READ MORE >
5 things to know in life sciences: Week of April 26
This week we highlight why people may be skipping their second COVID-19 dose, challenges of AI in patient diagnosis, the evolution of the regulatory environment for biopharma companies and more. … READ MORE >
5 things to know in life sciences: Week of April 19
This week our senior analysts highlight FDA approval decisions, venture funds focused on life sciences, newly approved remote patient monitoring devices and more. … READ MORE >
5 things to know in life sciences: Week of April 12
This week we highlight the backstory of challenges that have haunted the AstraZeneca vaccine efforts, machine learning that improves drug delivery, genetically modified mosquitoes and more. … READ MORE >
5 things to know in life sciences: Week of April 5
This week we highlight vaccine mandate considerations, the lack of diversity on the boards of life sciences companies, a promising new class of drugs and more. … READ MORE >
5 things to know in life sciences: Week of March 29
From biopharma merger scrutiny to AI-powered biology research, we highlight what’s happening in the life sciences industry this week. … READ MORE >
CHART OF THE DAY: FTC challenges biopharma merger as antitrust scrutiny grows
Less than two weeks after the Federal Trade Commission announced it would be taking a more stringent look at mergers in the biopharmaceutical industry, the proposed Illumina and Grail merger became only the second vertical merger in 40 years to be legally challenged by the agency. … READ MORE >
5 things to know in life sciences: Week of March 15
This week we highlight possible heightened scrutiny related to pharma mergers, top drugs losing their exclusivity this year, artificial intelligence-powered hearing aids and more. … READ MORE >